ACG Wealth’s Aurora Cannabis ACB Stock Holding History

ACG Wealth’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-22	Closed	–	–	250
2022 Q2	$0	Buy	+22	New	+$551	﹤0.01%	899

Other funds holding ACB

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACG Wealth's ACB Position: Q3 2022 in Review

ACG Wealth sold out of Aurora Cannabis (ACB) in Q3 2022, closing a stake of 22 shares.

ACG Wealth first reported a position in ACB in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 238 funds tracked by Wall St. Rank hold ACB as of Q3 2022.

ACG Wealth reported no remaining Aurora Cannabis position as of Q3 2022 after selling out during the quarter.
ACG Wealth sold 22 Aurora Cannabis shares in Q3 2022.
ACG Wealth first reported a position in Aurora Cannabis in Q2 2022 and held it in 1 quarter.
ACG Wealth's Aurora Cannabis position peaked at $0 in Q2 2022.
238 funds tracked by Wall St. Rank held Aurora Cannabis as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.